Clinical trial
The Study of Tamoxifen Treatment in Patients With Motor Neuron Disease
NCT02166944 is registered in ClinicalTrials.gov with Taipei Medical University Shuang Ho Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study of Tamoxifen Treatment in Patients With Motor Neuron Disease
- Lead sponsor
- Taipei Medical University Shuang Ho Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- September 18, 2019
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
als functional ration scale, amyotrophic lateral sclerosis, mtor, tamoxifen, tar-dna-binding protein-43